Additionally, it is imperative for future investigations to incorporate prospective data from renal cell carcinoma (RCC) patients and conduct in vitro experiments to validate the impact of SLC7A11 or GPX4 on the malignant biological behavior of RCC cells, thereby reinforcing the findings presented in this study. The gene discussed is SLC7A11; the disease is hereditary clear cell renal cell carcinoma.